These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13678773)

  • 1. The effects of hormone replacement therapy on cortical bone in postmenopausal women. A histomorphometric study.
    Vedi S; Bell KL; Loveridge N; Garrahan N; Purdie DW; Compston JE
    Bone; 2003 Sep; 33(3):330-4. PubMed ID: 13678773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy.
    Vedi S; Purdie DW; Ballard P; Bord S; Cooper AC; Compston JE
    Osteoporos Int; 1999; 10(1):52-8. PubMed ID: 10501780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
    Weinstein RS; Parfitt AM; Marcus R; Greenwald M; Crans G; Muchmore DB
    Osteoporos Int; 2003 Oct; 14(10):814-22. PubMed ID: 14610642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women.
    Vedi S; Compston JE
    Bone; 1996 Nov; 19(5):535-9. PubMed ID: 8922654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women.
    Eriksen EF; Langdahl B; Vesterby A; Rungby J; Kassem M
    J Bone Miner Res; 1999 Jul; 14(7):1217-21. PubMed ID: 10404024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histomorphometric study of cortical bone of the iliac crest in patients treated with glucocorticoids.
    Vedi S; Elkin SL; Compston JE
    Calcif Tissue Int; 2005 Aug; 77(2):79-83. PubMed ID: 16086108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling?
    Bord S; Vedi S; Beavan SR; Horner A; Compston JE
    Bone; 2000 Sep; 27(3):397-401. PubMed ID: 10962351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women.
    Huang AJ; Ettinger B; Vittinghoff E; Ensrud KE; Johnson KC; Cummings SR
    J Bone Miner Res; 2007 Nov; 22(11):1791-7. PubMed ID: 17620054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women.
    Boivin G; Vedi S; Purdie DW; Compston JE; Meunier PJ
    Bone; 2005 Mar; 36(3):562-7. PubMed ID: 15777681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.
    Tobias JH; Clarke S; Mitchell K; Robins S; Amer H; Fraser WD
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women.
    Sharp CA; Evans SF; Risteli L; Risteli J; Worsfold M; Davie MW
    Eur J Clin Invest; 1996 Sep; 26(9):763-71. PubMed ID: 8889438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study.
    Khastgir G; Studd J; Holland N; Alaghband-Zadeh J; Fox S; Chow J
    J Clin Endocrinol Metab; 2001 Jan; 86(1):289-95. PubMed ID: 11232014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ; Chesnut CH; Mallinak NJ
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1904-10. PubMed ID: 9177404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
    Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
    J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone effects of transdermal hormone replacement therapy in postmenopausal women as evaluated by means of ultrasound: an open one-year prospective study.
    de Aloysio D; Rovati LC; Cadossi R; Paltrinieri F; Mauloni M; Mura M; Penacchioni P; Ventura V
    Maturitas; 1997 May; 27(1):61-8. PubMed ID: 9158079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
    J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.